Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Primaquine adherence"'
Autor:
Irfanul Chakim, Tepanata Pumpaibool
Publikováno v:
Indian Journal of Public Health Research & Development.
Background: Plasmodium vivax is one of malaria parasite species that can lead to life-threatening disease. Primaquine is the only known and licensed drug prominently against Plasmodium vivax hypnozoites stage. However, lack studies have demonstrated
Autor:
Price, David J.1,2 (AUTHOR), Nekkab, Narimane3,4 (AUTHOR), Monteiro, Wuelton M.5,6 (AUTHOR), Villela, Daniel A. M.7 (AUTHOR), Simpson, Julie A.2 (AUTHOR), Lacerda, Marcus V. G.5,8 (AUTHOR), White, Michael T.9 (AUTHOR), Devine, Angela2,10,11 (AUTHOR) angela.devine@menzies.edu.au
Publikováno v:
PLoS Medicine. 1/9/2024, Vol. 21 Issue 1, p1-17. 17p.
Autor:
Annisa Rahmalia, Jeanne Rini Poespoprodjo, Chandra U. R. Landuwulang, Maya Ronse, Enny Kenangalem, Faustina H. Burdam, Kamala Thriemer, Angela Devine, Ric N. Price, Koen Peeters Grietens, Benedikt Ley, Charlotte Gryseels
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background Reducing the risk of recurrent Plasmodium vivax malaria is critical for malaria control and elimination. Primaquine (PQ) is the only widely available drug against P. vivax dormant liver stages, but is recommended as a 14-day regim
Externí odkaz:
https://doaj.org/article/6da2e98274d749c993482c5971e4eea8
Autor:
chakim, Irfanul, pumpaibool, Tepanata
Publikováno v:
Indian Journal of Public Health Research & Development; Jul2020, Vol. 11 Issue 7, p1255-1261, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nekkab, Narimane1 (AUTHOR) narimane.nekkab@pasteur.fr, Lana, Raquel2 (AUTHOR), Lacerda, Marcus3,4 (AUTHOR), Obadia, Thomas1 (AUTHOR), Siqueira, André5 (AUTHOR), Monteiro, Wuelton3,6 (AUTHOR), Villela, Daniel2 (AUTHOR), Mueller, Ivo1,7,8 (AUTHOR), White, Michael1 (AUTHOR) narimane.nekkab@pasteur.fr
Publikováno v:
PLoS Medicine. 4/23/2021, Vol. 18 Issue 4, p1-19. 19p. 1 Diagram, 4 Charts, 1 Graph, 1 Map.
Autor:
David J Price, Narimane Nekkab, Wuelton M Monteiro, Daniel A M Villela, Julie A Simpson, Marcus V G Lacerda, Michael T White, Angela Devine
Publikováno v:
PLoS Medicine, Vol 21, Iss 1, p e1004255 (2024)
BackgroundMalaria transmission modelling has demonstrated the potential impact of semiquantitative glucose-6-phosphate dehydrogenase (G6PD) testing and treatment with single-dose tafenoquine for Plasmodium vivax radical cure but has not investigated
Externí odkaz:
https://doaj.org/article/f2e00a5e586a415a95fa4161f602abd0
Autor:
Mehdipour, Parinaz1 (AUTHOR), Rajasekhar, Megha1 (AUTHOR), Dini, Saber1 (AUTHOR), Zaloumis, Sophie1 (AUTHOR), Abreha, Tesfay2 (AUTHOR), Adam, Ishag3 (AUTHOR), Awab, Ghulam Rahim4,5 (AUTHOR), Baird, J. Kevin6,7 (AUTHOR), Brasil, Larissa W.8,9 (AUTHOR), Chu, Cindy S.7,10 (AUTHOR), Cui, Liwang11 (AUTHOR), Daher, André12 (AUTHOR), do Socorro M Gomes, Margarete13,14 (AUTHOR), Gonzalez‑Ceron, Lilia15 (AUTHOR), Hwang, Jimee16,17 (AUTHOR), Karunajeewa, Harin18 (AUTHOR), Lacerda, Marcus V. G.19,20,21 (AUTHOR), Ladeia-Andrade, Simone22,23 (AUTHOR), Leslie, Toby24,25 (AUTHOR), Ley, Benedikt26 (AUTHOR)
Publikováno v:
Malaria Journal. 10/10/2023, Vol. 22 Issue 1, p1-14. 14p.
Publikováno v:
Frontiers in Public Health; 2024, p1-7, 7p
Publikováno v:
Zika & Mosquito Week; 6/22/2023, p7401-7401, 1p